Lexaria Bioscience (LEXX) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Lexaria Bioscience has formed a new Scientific Advisory Board to enhance its drug delivery platform technology, with John Docherty, a seasoned expert in the pharmaceutical sector, as the Chairman. The board, comprising experts in pharmaceutical development, aims to guide the company’s strategic plans towards successful commercialization.
For further insights into LEXX stock, check out TipRanks’ Stock Analysis page.
